Absence of pulmonary artery growth after fontan operation and its possible impact on late outcome

Stanislav Ovroutski1, Peter Ewert, Vladimir Alexi-Meskishvili

  • 1Department of Congenital Heart Diseases, German Heart Institute Berlin, Berlin, Germany. ovroutski@dhzb.de

Insights

Pulmonary arteries (PAs) in children show reduced growth after Fontan operation, despite normal body growth. This impaired PA development may limit long-term Fontan circulation effectiveness.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Vascular Biology

Background:

  • The Fontan operation is a palliative procedure for complex single-ventricle congenital heart defects.
  • Long-term outcomes after Fontan palliation are influenced by various factors, including pulmonary artery development.

Purpose of the Study:

  • To evaluate the long-term development of pulmonary arteries (PAs) in children following a Fontan operation.
  • To assess the relationship between PA growth, somatic growth, and Fontan circulation outcomes.

Main Methods:

  • Angiographic measurements of central and lower lobe PA diameters were taken before and after Fontan operation in 35 patients.
  • Body surface area-adjusted PA indices were calculated and compared between preoperative and follow-up assessments.
  • Correlations between PA indices, follow-up duration, and clinical outcomes were investigated.

Main Results:

  • Despite parallel somatic growth, pulmonary arteries showed no significant increase in diameter post-Fontan operation.
  • The PA index and lower lobe index significantly decreased during the follow-up period.
  • A lower PA index correlated with a longer follow-up duration and unfavorable Fontan outcomes.

Conclusions:

  • Pulmonary artery growth is significantly restricted after the Fontan operation, even with normal somatic development.
  • Reduced PA growth may increase pulmonary vascular resistance, potentially limiting the long-term efficacy of Fontan circulation.
  • This finding highlights a critical factor affecting the long-term management of Fontan patients.
Abstract